KROS
Keros Therapeutics Inc
11.40$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -118.4% | – | -940.0% | – | – | – | |
| – | +17.6% | +12.1% | +10.5% | +2.6% | +5.7% | +3.6% | +7.6% | +6.8% | +1.3% | +0.8% | -0.2% | – | |
| – | -15.9% | +10.2% | +8.9% | +0.4% | +4.3% | -3.7% | -3.6% | -53.3% | +83.3% | -15.1% | -13.3% | – | |
| – | – | -247.3% | – | – | -179.0% | – | -387.5% | – | -319.5% | – | -85.6% | – | |
| – | -1.6% | +74.9% | -67.2% | +24.5% | -25.1% | +95.5% | +27.4% | -81.7% | +1.5% | -45.5% | +112.3% | – | |
| – | -1.6% | +74.9% | -67.2% | +24.5% | -25.1% | +95.5% | +27.4% | -81.7% | +1.5% | -45.5% | +112.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +24,285.2% | +126.4% | -97.7% | +4,316.4% | -51.6% | -100.0% | +325.0% | +723.5% | -270,550.7% | -99.4% | +43.1% | – | |
| – | – | +157.3% | -132.9% | – | -76.6% | +449.2% | -118.9% | – | -12,567.2% | – | – | – | |
| – | – | – | – | – | – | – | -118.9% | – | -979.9% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.